Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOptiscan Imaging Ltd

Optiscan Imaging Ltd

Technology Scientific & Technical Instruments
PortfolioPortfolio WatchlistWatchlist
Company price
0.165 AUD 0.01 ( 6.45%)
Last update at 2026-11-06T04:42:00Z
VOLUME
199549
Market Cap
162.07M

Momentum Score

…

Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.15
Low
0.17
High
52 Week Price Range
0.08
Low
0.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Optiscan Imaging Ltd develops and sells high-resolution in vivo optical imaging systems and probe technologies for medical and research applications, focused on minimally invasive microscopic visualization. The company appears positioned to benefit from increasing demand for real-time minimally invasive diagnostics, broader clinical adoption of optical biopsy techniques, and potential geographic and application expansion that could support recurring consumables and service revenue.

Key risks include limited commercial scale and financing constraints, ongoing regulatory and reimbursement hurdles, and competition from larger imaging firms that could impede adoption and cash flow.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.15
Dividend Yield
-
Revenue TTM
3.61M
Revenue Per Share
0.00
Gross Profit TTM
3.35M
Debt / Equity
0.07
ROE
-52.41%
Net Debt
-13.01M
ROCE
-52.62%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -9.37M -6.29M -6.06M -4.35M -4.23M
Net income -6.99M -6.31M -6.06M -4.35M -4.23M
Selling general administrative - 4.17M 4.35M 3.60M 1.65M
Selling and marketing expenses - 0.16M 0.23M - -
Gross profit -0.79M 3.25M 0.63M 1.13M -2.69M
Reconciled depreciation - 0.43M 0.57M 0.38M 0.24M
Ebit -10.60M -6.60M -7.03M -4.32M -4.20M
Ebitda -10.28M -6.49M -6.46M -3.94M -3.96M
Depreciation and amortization 0.32M 0.11M 0.57M 0.38M 0.24M
Operating income -10.60M -6.17M -8.41M -4.35M -4.23M
Other operating expenses 11.05M 9.90M 9.57M 0.87M 0.93M
Interest expense 0.08M 0.03M 0.02M 0.03M 0.03M
Tax provision - 0.02M 0.00M 0.00M 0.00M
Interest income - 0.33M 0.55M 0.03M 0.02M
Net interest income - 0.31M 0.52M -0.00M -0.01M
Income tax expense -2.39M 0.02M -0.99M 0.97M 1.28M
Total revenue 0.45M 3.72M 1.16M 1.68M 1.01M
Total operating expenses 9.81M 9.42M 9.04M 6.42M 6.48M
Cost of revenue 1.24M 0.47M 0.53M 0.55M 3.70M
Total other income expense net 1.23M -0.12M 2.35M 0.94M 1.25M
Net income from continuing ops - -6.31M -6.06M -4.35M -4.23M
Net income applicable to common shares - -6.31M -6.06M -4.35M -4.23M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 22.03M 10.56M 15.63M 4.67M 7.98M
Intangible assets 0.00M 0.00M - 0.45M 0.45M
Other current assets 0.83M 0.51M 5.40M 0.30M 0.11M
Total liab 3.08M 2.84M 1.76M 1.63M 1.39M
Total stockholder equity 18.94M 7.71M 13.87M 3.04M 6.59M
Other current liab 1.02M - 0.99M 0.90M 0.72M
Common stock 106.10M - 88.53M 71.86M 71.26M
Capital stock - 88.53M - 71.86M 71.26M
Retained earnings -88.29M -81.31M -75.24M -70.94M -66.89M
Other liab - - - 0.02M 0.02M
Other assets - - - 0.00M 0.05M
Cash 14.35M 4.55M 6.10M 0.88M 4.53M
Total current liabilities 1.88M 1.51M 1.75M 1.42M 1.00M
Current deferred revenue - - - -0.23M -0.20M
Net debt -13.01M - -5.88M -0.46M -3.98M
Short term debt 0.18M - 0.22M 0.23M 0.18M
Short long term debt - 0.03M - 0.04M -
Short long term debt total 1.34M - 0.22M 0.41M 0.55M
Other stockholder equity - - - -0.92M -4.36M
Property plant equipment - - - 0.58M 0.61M
Total current assets 20.38M 8.86M 15.07M 3.65M 7.32M
Long term investments - - - - 0.05M
Net tangible assets - - - 2.59M 6.59M
Short term investments - - - 0.05M 0.05M
Net receivables 2.85M 0.32M 1.57M 0.98M 1.41M
Inventory 2.35M 1.67M 2.00M 1.44M 1.27M
Accounts payable 0.68M 0.37M 0.54M 0.52M 0.30M
Accumulated other comprehensive income 1.14M - 0.58M 2.12M 2.23M
Non currrent assets other - - 0.16M -1.03M -0.45M
Non current assets total 1.65M 1.69M 0.56M 1.03M 0.66M
Capital lease obligations - 1.45M - 0.37M 0.55M
Long term debt total - - - 0.18M 0.37M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - 5.05M -5.23M -0.13M -0.12M
Change to liabilities - - - 0.37M -0.07M
Total cashflows from investing activities -0.26M 5.05M -5.23M -0.13M -0.12M
Net borrowings - -0.17M -0.20M -0.42M -0.20M
Total cash from financing activities 17.17M -0.38M 16.21M -0.37M 0.04M
Change to operating activities - - - -0.16M 0.10M
Net income -6.99M -6.31M -6.06M -4.35M -4.23M
Change in cash 9.80M -1.55M 5.23M -3.65M -3.91M
Begin period cash flow 4.55M 6.10M 0.88M 4.53M 8.44M
End period cash flow 14.35M 4.55M 6.10M 0.88M 4.53M
Total cash from operating activities -7.10M -6.21M -5.74M -3.16M -3.83M
Issuance of capital stock - - 16.72M 0.04M 0.24M
Depreciation 0.32M 0.43M 0.57M 0.38M 0.24M
Other cashflows from investing activities - 5.14M -5.15M - -
Dividends paid - - - - 0.42M
Change to inventory -0.67M 0.33M -0.56M -0.17M -0.11M
Change to account receivables -0.72M -0.56M -0.59M 0.44M -0.17M
Sale purchase of stock - 0.00M -0.10M 0.04M -0.20M
Other cashflows from financing activities -0.25M -0.17M -0.21M -0.23M -0.12M
Change to netincome - - - 0.32M 0.41M
Capital expenditures 0.26M 0.09M 0.09M 0.13M 0.12M
Change in working capital -1.16M -0.43M -0.54M 0.27M -0.28M
Stock based compensation - 0.16M 0.23M 0.23M 0.38M
Other non cash items 0.72M -0.05M 0.29M 0.81M 0.16M
Free cash flow -7.36M -6.31M -5.83M -3.29M -3.96M

Peer Comparison*

Sector: Technology Industry: Scientific & Technical Instruments

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OIL
Optiscan Imaging Ltd		 0.01
6.45%		 0.17 - 10.82 44.85 8.28 320.51 -12.11
CDA
Codan Ltd		 -1.63
2.90%		 54.49 58.46 36.76 11.69 17.92 12.47 38.25
CAT
Catapult Group International Ltd		 -0.06
1.60%		 3.68 - 49.02 8.40 3.56 5.03 46.83
IKE
Ikegps Group Ltd		 0.01
0.74%		 0.68 - - 4.96 6.72 5.61 -3.62
SMN
Structural Monitoring Systems Plc		 0.01
4.48%		 0.35 33.50 3.23 1.62 2.22 1.60 10.59

Profile*

Optiscan Imaging Ltd

Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

16 Miles Street, Mulgrave, VIC, Australia, 3170

61 3 9538 3333

https://www.optiscan.com

Name Title Year Born
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Exec. Director NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Sec. NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…